Drugs / JuvedermⓇ
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06574750 Comparator | Oct 2021 → May 2023 | — | Seoul National University Bundang Hospital | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JuvedermⓇ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06574750 ↗ |
| Known as | Juvéderm | “This study aimed to evaluate the efficacy and safety of a new monophasic HA filler, Curea, for NLF correction compared with the widely used Juvéderm.” PMID 40707029 ↗ Jul 2025 |